Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease.

Calabrò, Paolo; Gragnano, Felice; Niccoli, Giampaolo; Marcucci, Rossella; Zimarino, Marco; Spaccarotella, Carmen; Renda, Giulia; Patti, Giuseppe; Andò, Giuseppe; Moscarella, Elisabetta; Mancone, Massimo; Cesaro, Arturo; Giustino, Gennaro; De Caterina, Raffaele; Mehran, Roxana; Capodanno, Davide; Valgimigli, Marco; Windecker, Stephan; Dangas, George D; Indolfi, Ciro; ... (2021). Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease. Circulation, 144(16), pp. 1323-1343. American Heart Association 10.1161/CIRCULATIONAHA.121.054305

[img] Text
Antithrombotic.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (2MB)

Contemporary evidence supports device-based transcatheter interventions for the management of patients with structural heart disease. These procedures, which include aortic valve implantation, mitral or tricuspid valve repair/implantation, left atrial appendage occlusion, and patent foramen ovale closure, profoundly differ with respect to clinical indications and procedural aspects. Yet, patients undergoing transcatheter cardiac interventions require antithrombotic therapy before, during, or after the procedure to prevent thromboembolic events. However, these therapies are associated with an increased risk of bleeding complications. To date, challenges and controversies exist regarding balancing the risk of thrombotic and bleeding complications in these patients such that the optimal antithrombotic regimens to adopt in each specific procedure is still unclear. In this review, we summarize current evidence on antithrombotic therapies for device-based transcatheter interventions targeting structural heart disease and emphasize the importance of a tailored approach in these patients.

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Valgimigli, Marco, Windecker, Stephan

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1524-4539

Publisher:

American Heart Association

Language:

English

Submitter:

Nadia Biscozzo

Date Deposited:

20 Jan 2022 11:29

Last Modified:

05 Dec 2022 15:59

Publisher DOI:

10.1161/CIRCULATIONAHA.121.054305

PubMed ID:

34662163

Uncontrolled Keywords:

anticoagulants atrial appendage atrial fibrillation foramen ovale, patent mitral valve thrombosis transcatheter aortic valve replacement

BORIS DOI:

10.48350/163182

URI:

https://boris.unibe.ch/id/eprint/163182

Actions (login required)

Edit item Edit item
Provide Feedback